Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SVM | NWL |
|---|---|---|
| Price | $10.55 | $5.48 |
| Change today | ▼ 0.28% | ▲ 1.48% |
| Market cap | $2.33B | $2.33B |
| Return, 3 months | +12.6% | +0.1% |
| Return, year to date | +26.6% | +54.3% |
| Return, 1 year | +47.5% | +11.5% |
| P/E (TTM) | 95.9 | -10.3 |
| P/B | 2.4 | 1.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.24% | 5.11% |
| Revenue growth (YoY, latest qtr) | – | -5.0% |
| Net profit growth (YoY) | – | -31.9% |
| Gross margin | – | 33.8% |
| Operating margin | – | 6.5% |
| Net margin | – | -4.0% |
| Return on equity | – | – |
| Analyst target vs. price | +37.3% | +28.5% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 38 | 45 |
| 30-day volatility | 55.1% | 37.9% |
| Max drawdown, 1 year | -43.8% | -43.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
